Jahresbericht 2006 - Caritas-Krankenhaus St. Josef Regensburg

7) Klinische Studien
Finasterid-basierte Diagnostik des Prostatakarzinoms bei Patienten mit BPH
Investigator: Blana Coinvestigator:Siebert
Prostatakarzinom – Phase III Studie
Vergleichsstudie testosteron-supprimierender Substanzen GnRh-Antagonist (Degarelix) zu
GnRh-Agonisten
Principal investigator: Blana Coinvestigator: Ganzer, Siebert
Zelluläre Immuntherapie zur adjuvanten Immuntherapie des nicht-invasiven
Harnblasenkarzinoms (Bexidem); Immuno-designed Molecules (IDM), Paris.
Studienzentrum: Klinik für Urologie der Universität Regensburg. Principal Investigator:
Burger, Coinvestigator: Denzinger.
Photodynamische Diagnostik in der Resektion des Urothelkarzinoms der Harnblase mit 5-
ALA-Hexylesther; Photocure SA, Oslo. Investigator: Prof. Rößler, Coinvestigator:
Denzinger, Burger.
ReForM C Project 3a Impact of the metabolic syndrome on the development of benign
prostatic hyperplasia (BPH)
Lunz, Borchardt
ReForM C Project 3b Impact of the metabolic syndrome on the expression of DNA
Methyltransferases and the promoter hypermethylation of the GSTP1 gene in prostate
cancer
Lunz, Borchardt
A multi-center, randomized, double blind, placebo controlled study to investigate the
efficiacy and safety of Aprotinin on transfusion requirements in patients with bladder
cancer undergoing radical cystectomy. (Aprotinin-Studie)
Lunz, Straub
A randomized, explorative, double-blind, double-dummy, multi-center, parallel group study
to assess sustainable efficacy of once daily vardenafil (10mg) for 12 and 24 weeks versus
vardenafil PRN in men with mild to moderate erectile dysfunction. (Vardenafil-Studie).
Lunz
Lebensqualität nach Therapie des lokoregionären Prostatakarzinoms
Lunz
23